Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-07-17FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)
FDA approved the original ANDA for Fluorouracil by Eugia US LLC, enabling the marketing of a generic fluorouracil chemotherapy product.
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer [NA]
This clinical trial investigating pre-treatment with HPPH photodynamic therapy before chemoradiation for non-operable obstructive esophageal…
-
CLINICAL_TRIALS research · 2012-06-28Clinical Trial Update: IMRT/Pemetrexed/Cisplatin in Esophageal Cancer
This document provides an update on a clinical trial studying a combination of IMRT, pemetrexed, and cisplatin for esophageal cancer. The tr…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer [NA]
This document provides an update on a completed clinical trial evaluating endobronchial ultrasound (EBUS) for nodal staging in esophageal ca…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus [Phase 2]
Phase 2 trial S0101 evaluating a gemcitabine and irinotecan combination for metastatic or recurrent esophageal and gastric cancer has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer [Phase 2]
Clinical trial update indicates termination of a Phase 2 study combining chemotherapy and interferon alfa followed by surgery and/or radiati…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a combination of cetuximab, docetaxel, cisplatin, and radiation therapy for locally advanced, surgical…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant therapy with docetaxel and cisplatin plus chemoradiotherapy followed by surgery for locally advanced,…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating docetaxel, cisplatin, and radiation therapy for locally advanced, unresectable esophageal cancer; study has complet…
-
CLINICAL_TRIALS research · 2012-05-25Clinical Trial Update: Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma
This update summarizes a clinical trial evaluating whether FDG-PET scans performed during radiotherapy can predict treatment outcomes in eso…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating combination chemotherapy plus radiation therapy for advanced or me…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer [Phase 2]
Phase 2 trial evaluating irinotecan, cisplatin, and radiation therapy with or without celecoxib for Stage II–IV esophageal cancer; the study…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Metastatic Stomach Cancer [Phase 2]
Phase 2 clinical trial update on DX-8951f for metastatic gastric cancer and esophageal cancer; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2012-05-09Clinical Trial Update: Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
A withdrawn clinical trial update analyzing real-life safety outcomes of photodynamic therapy in esophageal cancer, lung cancer, and Barrett…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer [Phase 1]
Phase 1 trial of an HLA-A*2402 restricted peptide vaccine for advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction [Phase 2]
A Phase 2 SWOG trial evaluating a multimodal regimen of oxaliplatin, 5-fluorouracil, radiation therapy, and surgery for stage II-III esophag…
-
CLINICAL_TRIALS research · 2012-04-02Clinical Trial Update: a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent [Phase 3]
A multicentric randomized Phase 3 trial is evaluating a self-expandable esophageal radiation stent for esophageal cancer; the update provide…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer
This completed clinical trial investigated venous thromboembolism and haemostatic disturbances in patients with upper gastrointestinal cance…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [Phase 1]
A Phase 1 trial of a combination chemotherapy regimen for patients with recurrent, refractory, or metastatic solid tumors and lymphomas has …
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluating Gefitinib for recurrent or metastatic esophageal or gastroesophageal junction cancer has completed, with…
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS research · 2012-03-08Clinical Trial Update: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [Phase 1, Phase 2]
This clinical trial update examines the combination of epirubicin, carboplatin, and capecitabine in patients with unresectable locally advan…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer [Phase 1]
Phase 1 trial evaluating S-1 plus nedaplatin with concurrent radiotherapy for advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer [Phase 1]
Phase 1 trial update evaluating S-1 with radiotherapy in elderly patients with esophageal cancer. The study has completed.